InvestorsObserver
×
News Home

Where Does Actinium Pharmaceuticals Inc (ATNM) Stock Fall in the Biotechnology Field After It Is Up 33.40% This Week?

Thursday, April 14, 2022 01:15 PM | InvestorsObserver Analysts

Mentioned in this article

Where Does Actinium Pharmaceuticals Inc (ATNM) Stock Fall in the Biotechnology Field After It Is Up 33.40% This Week?

Actinium Pharmaceuticals Inc (ATNM) is near the top in its industry group according to InvestorsObserver. ATNM gets an overall rating of 64. That means it scores higher than 64 percent of stocks. Actinium Pharmaceuticals Inc gets a 89 rank in the Biotechnology industry. Biotechnology is number 64 out of 148 industries.

Overall Score - 64
ATNM has an Overall Score of 64. Find out what this means to you and get the rest of the rankings on ATNM!

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.
These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Actinium Pharmaceuticals Inc Stock Today?

Actinium Pharmaceuticals Inc (ATNM) stock is trading at $6.87 as of 1:13 PM on Thursday, Apr 14, a decline of -$0.10, or -1.43% from the previous closing price of $6.97. The stock has traded between $6.63 and $7.34 so far today. Volume today is 1,609,634 compared to average volume of 1,324,583. Click Here to get the full Stock Report for Actinium Pharmaceuticals Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App